Clearmind Medicine Inc. short interest in 2023

In 2023, Clearmind Medicine Inc.'s disclosed short interest ran from 3.29% of shares outstanding on 13 Jan 2023 to 53.02% on 31 Oct 2023, a change of +49.73 percentage points. The year's high was 53.02% on 31 Oct 2023 and its low 3.29% on 13 Jan 2023, averaging 13.18% across 7 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.24 days on 14 Jul 2023. Full history: Clearmind Medicine Inc..

Cite this page

Plain

Short position data for Clearmind Medicine Inc. short interest in 2023: FINRA, compiled by howshorted.com, settlement date 31 Oct 2023. https://howshorted.com/us/company/cmnd/2023/

Wikipedia

<ref>{{cite web |title=Clearmind Medicine Inc. short interest in 2023 short position data |url=https://howshorted.com/us/company/cmnd/2023/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2023-10-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-clearmind-medicine-inc-short-interest-in-2023-10-31,
  title        = {Clearmind Medicine Inc. short interest in 2023 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/cmnd/2023/}},
  note         = {Data: FINRA, settlement date 31 Oct 2023; accessed 2026-10-13},
  year         = {2023}
}

By year: 2023 · 2025

2023 in figures

Start of year: 3.29% (13 Jan 2023)
End of year: 53.02% (31 Oct 2023)
Change: +49.73 pp
High: 53.02% (31 Oct 2023)
Low: 3.29% (13 Jan 2023)
Average: 13.18%
Highest days to cover: 1.24 (14 Jul 2023)
SEC filings marked: 1

Every report in 2023

Clearmind Medicine Inc. short interest in 2023
Settlement	Short interest	Days to cover	Filings since previous
13 Jan 2023	3.29%	1.00
15 Mar 2023	4.51%	1.00	20-F filed
31 Mar 2023	5.46%	1.00
15 Jun 2023	11.17%	1.06
30 Jun 2023	7.68%	1.00
14 Jul 2023	7.10%	1.24
31 Oct 2023	53.02%	1.00

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.